Authors:
Rueffer, U
Breuer, K
Josting, A
Lathan, B
Sieber, M
Manzke, O
Grotenhermen, FJ
Tesch, H
Bredenfeld, H
Koch, P
Nisters-Backes, H
Wolf, J
Engert, A
Diehl, V
Citation: U. Rueffer et al., Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment, ANN ONCOL, 12(9), 2001, pp. 1307-1311
Authors:
Pfreundschuh, M
Hasenclever, D
Loeffler, M
Ehninger, G
Schmitz, N
Kirchner, H
Koch, P
Lathan, B
Rueffer, U
Sextro, M
Franklin, J
Tesch, H
Diehl, V
Citation: M. Pfreundschuh et al., Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF, ANN ONCOL, 12(4), 2001, pp. 471-477
Authors:
Duhmke, E
Franklin, J
Pfreundschuh, M
Sehlen, S
Willich, N
Ruhl, U
Muller, RP
Lukas, P
Atzinger, A
Paulus, U
Lathan, B
Ruffer, U
Sieber, M
Wolf, J
Engert, A
Georgii, A
Staar, S
Herrmann, R
Beykirch, M
Kirchner, H
Emminger, A
Greil, R
Fritsch, E
Koch, P
Drochtert, A
Brosteanu, O
Hasenclever, D
Loeffler, M
Diehl, V
Citation: E. Duhmke et al., Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone, J CL ONCOL, 19(11), 2001, pp. 2905-2914
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Ruffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duhmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP: A new regimen for advanced Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 67-71
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Rueffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duehmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group, J CL ONCOL, 16(12), 1998, pp. 3810-3821
Authors:
Tesch, H
Diehl, V
Lathan, B
Hasenclever, D
Sieber, M
Ruffer, U
Engert, A
Franklin, J
Pfreundschuh, M
Schalk, KP
Schwieder, G
Wulf, G
Dolken, G
Worst, P
Koch, P
Schmitz, N
Bruntsch, U
Tirier, C
Muller, U
Loeffler, M
Citation: H. Tesch et al., Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: A study of the German Hodgkin's Lymphoma Study Group, BLOOD, 92(12), 1998, pp. 4560-4567